Clinical Trial Update: Aflibercept in Recurrent or Persistent CNV

View source ↗

Summary

This clinical trial update indicates recruitment for a study of aflibercept in recurrent or persistent choroidal neovascularization. The conditions include age-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Medical University of Vienna | Conditions: Age Related Macular Degeneration, Intravitreal Injections | Status: RECRUITING